SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-16-744528
Filing Date
2016-10-24
Accepted
2016-10-24 07:58:02
Documents
5
Period of Report
2016-10-21
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d276876d8k.htm 8-K 13850
2 EXHIBIT 99.1 d276876dex991.htm EX-99.1 15543
3 EXHIBIT 99.2 d276876dex992.htm EX-99.2 6502
4 GRAPHIC g276876img001.jpg GRAPHIC 10514
5 GRAPHIC g276876img01.jpg GRAPHIC 437004
  Complete submission text file 0001193125-16-744528.txt   653837
Mailing Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109
Business Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109 857-246-8998
PIERIS PHARMACEUTICALS, INC. (Filer) CIK: 0001583648 (see all company filings)

IRS No.: 300784346 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37471 | Film No.: 161947251
SIC: 8731 Services-Commercial Physical & Biological Research